Cargando…

Hypercholesterolemia Causes Circadian Dysfunction: A Potential Risk Factor for Cardiovascular Disease

Hypercholesterolemia is a well-known risk factor for a wide range of diseases in developed countries. Here, we report that mice lacking functional LDLR (low density lipoprotein receptor), an animal model of human familial hypercholesterolemia, show circadian abnormalities. In free running behavioral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akashi, Makoto, Matsumura, Ritsuko, Matsuo, Takahiro, Kubo, Yuki, Komoda, Hiroshi, Node, Koichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478205/ https://www.ncbi.nlm.nih.gov/pubmed/28499924 http://dx.doi.org/10.1016/j.ebiom.2017.04.034

Ejemplares similares

Detection of endogenous circadian rhythms of clock gene mRNA expression in mouse lung tissue using slice cultures
por: Matsumura, Ritsuko, et al.
Publicado: (2023)

Compensation for intracellular environment in expression levels of mammalian circadian clock genes
por: Matsumura, Ritsuko, et al.
Publicado: (2014)

A detection method for latent circadian rhythm sleep-wake disorder
por: Akashi, Makoto, et al.
Publicado: (2020)

A simple method using ex vivo culture of hair follicle tissue to investigate intrinsic circadian characteristics in humans
por: Yamaguchi, Ai, et al.
Publicado: (2017)

Bright light improves sleep in patients with Parkinson’s disease: possible role of circadian restoration
por: Endo, Takuyuki, et al.
Publicado: (2020)

In vivo evaluation of the effect of lithium on peripheral circadian clocks by real-time monitoring of clock gene expression in near-freely moving mice
por: Sawai, Yuka, et al.
Publicado: (2019)

An out-of-lab trial: a case example for the effect of intensive exercise on rhythms of human clock gene expression
por: Okamoto, Akihiko, et al.
Publicado: (2013)

Potential contribution of tandem circadian enhancers to nonlinear oscillations in clock gene expression
por: Tokuda, Isao T., et al.
Publicado: (2017)

Possible contribution of chronobiology to cardiovascular health
por: Sato, Miho, et al.
Publicado: (2014)

Deletion of Apoptosis Inhibitor of Macrophage (AIM)/CD5L Attenuates the Inflammatory Response and Infarct Size in Acute Myocardial Infarction
por: Nishikido, Toshiyuki, et al.
Publicado: (2016)

Azelnidipine Inhibits the Differentiation and Activation of THP-1 Macrophages through the L-Type Calcium Channel
por: Komoda, Hiroshi, et al.
Publicado: (2018)

Pentraxin-3 regulates the inflammatory activity of macrophages
por: Shiraki, Aya, et al.
Publicado: (2016)

Polygenic Hypercholesterolemia and Cardiovascular Disease Risk
por: Sharifi, Mahtab, et al.
Publicado: (2019)

Cardiorespiratory Fitness and the Risk of All-Cause, Cardiovascular and Cancer Mortality in Men with Hypercholesterolemia
por: Sui, Xuemei, et al.
Publicado: (2022)

Endothelial Microparticles as Potential Biomarkers in the Assessment of Endothelial Dysfunction in Hypercholesterolemia
por: Nik Ibrahim, Nik Nor Izah, et al.
Publicado: (2022)

Increased amputation risk with canagliflozin treatment: behind the large cardiovascular benefit?
por: Tanaka, Atsushi, et al.
Publicado: (2017)

Hypercholesterolemia and microvascular dysfunction: interventional strategies
por: Stapleton, Phoebe A, et al.
Publicado: (2010)

The in vitro real-time oscillation monitoring system identifies potential entrainment factors for circadian clocks
por: Nakahata, Yasukazu, et al.
Publicado: (2006)

Anti-obesity therapy for cardiovascular disease prevention: potential expected roles of glucagon-like peptide-1 receptor agonists
por: Sawami, Kosuke, et al.
Publicado: (2022)

Age-related circadian disorganization caused by sympathetic dysfunction in peripheral clock regulation
por: Tahara, Yu, et al.
Publicado: (2017)

Potential Effect of the Circadian Clock on Erectile Dysfunction
por: Li, Tao, et al.
Publicado: (2022)

Rheumatoid Arthritis and Vascular Failure - Rheumatoid Arthritis Is a Risk Factor for Cardiovascular Disease-
por: Oyama, Jun-ichi, et al.
Publicado: (2019)

Clinical application of glucagon-like peptide-1 receptor agonists in cardiovascular disease: lessons from recent clinical cardiovascular outcomes trials
por: Tanaka, Atsushi, et al.
Publicado: (2018)

Update on Familial Hypercholesterolemia: Diagnosis, Cardiovascular Risk, and Novel Therapeutics
por: Lee, Sang-Hak
Publicado: (2017)

Prevalence of high-risk cardiovascular patients with therapy-resistant hypercholesterolemia
por: Kostev, Karel, et al.
Publicado: (2017)

Phytosterols in the Treatment of Hypercholesterolemia and Prevention of Cardiovascular Diseases
por: Cabral, Carlos Eduardo, et al.
Publicado: (2017)

Current causes of death in familial hypercholesterolemia
por: Marco-Benedí, Victoria, et al.
Publicado: (2022)

Correlation Analysis Between Time Awareness and Morningness-Eveningness Preference
por: Sogawa, Reimi, et al.
Publicado: (2023)

Collective Knowledge Used to Unveil Cardiovascular Injury Emerged during COVID-19
por: Tanaka, Atsushi, et al.
Publicado: (2022)

How should we monitor the cardiovascular benefit of sodium–glucose cotransporter 2 inhibition?
por: Tanaka, Atsushi, et al.
Publicado: (2020)

Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE)
por: Sudano, Isabella, et al.
Publicado: (2022)

Circadian Rhythm of Cardiovascular Disease: The Potential of Chronotherapy With Aspirin
por: Buurma, Marleen, et al.
Publicado: (2019)

Risk of cardiovascular disease with lipoprotein(a) in familial hypercholesterolemia: a review
por: Watanabe, Jun, et al.
Publicado: (2020)

Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease
por: Trinder, Mark, et al.
Publicado: (2020)

Impact of Severe Hypercholesterolemia on Cardiovascular Risk in Individuals With or Without Diabetes Mellitus
por: Lee, Chan Joo, et al.
Publicado: (2022)

Correlation of cardiovascular risk predictors with overweight and obesity in patients with familial hypercholesterolemia
por: Wang, Yaodong, et al.
Publicado: (2022)

Association of Peripheral Arterial and Cardiovascular Diseases in Familial Hypercholesterolemia
por: Pereira, Carolina, et al.
Publicado: (2014)

A Novel Case of Pseudohyponatremia Caused by Hypercholesterolemia
por: Song, Lu, et al.
Publicado: (2018)

Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors
por: Tanaka, Atsushi, et al.
Publicado: (2021)

Familial Hypercholesterolemia Genetic Variations and Long-Term Cardiovascular Outcomes in Patients with Hypercholesterolemia Who Underwent Coronary Angiography
por: Lee, Wen-Jane, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nk463r374m2khfrplarktf69kg